A double-blind, randomized, placebo-controlled multicenter clinical trial to evaluate the effects of the angiotensin II receptor blocker candesartan cilexetil on intimal hyperplasia after coronary stent implantation. [electronic resource]
Producer: 20061018Description: 761.e1-6 p. digitalISSN:- 1097-6744
- Aged
- Angiotensin II Type 1 Receptor Blockers -- adverse effects
- Benzimidazoles -- adverse effects
- Biphenyl Compounds -- adverse effects
- Coronary Angiography
- Coronary Disease -- diagnosis
- Coronary Restenosis -- prevention & control
- Coronary Vessels -- pathology
- Double-Blind Method
- Female
- Follow-Up Studies
- Humans
- Hyperplasia
- Male
- Middle Aged
- Stents -- adverse effects
- Tetrazoles -- adverse effects
- Tunica Intima -- pathology
- Ultrasonography, Interventional
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.